Latest filing published 18 Jul 2017 for ALDER BIOPHARMACEUTICALS INC, €216k.
Filing timeline
BuySaleInsider track record
No signal scores available.
Closed purchases
Based on 7 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -14.2%Entry US$30.84 · Close at T+365 US$26.46
- +14.6%Entry US$42.66 · Close at T+365 US$48.90
- +13.8%Entry US$42.96 · Close at T+365 US$48.90
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Stephen M. Dow: trading record in brief
Stephen M. Dow discloses dealings in 4 companies, chiefly Citrix Systems Inc, Alder Biopharmaceuticals Inc and Cytokinetics Inc. We count 108 filings; the first trade dates from 13 February 2006 and the latest from 18 July 2017.
In open-market terms, that means 9 purchases worth €606k on one side and 55 sales worth €30.7M on the other. Netting one side against the other leaves €30.1M of net selling. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 12 share grants and 20 option exercises. So far in 2017, the count stands at 1 purchase and no sales.
In size, the median ticket on the buying side is €61k. For 7 purchases whose 90-day window has closed, the share price was higher on day 90 than the day after publication in 0% of cases, with a median move of -1.7%. They describe history only and say nothing certain about the share price ahead.
The latest filing, published on 18 July 2017, reports an open-market purchase of €216k in Alder Biopharmaceuticals Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Stephen M. Dow
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 25,000 shares@ US$10.00100.0% of flowCommon StockSEC:0001209191-17-045605:0Canonical exit: 16 Oct 2017 (T+90)
- 88 shares@ US$37.11Common StockSEC:0001179110-15-015619:0
- 16,218 shares@ US$38.75Common StockSEC:0001179110-15-012849:0
- 115,358 shares@ US$40.40Common StockSEC:0001179110-15-012103:0
- 97,109 shares@ US$40.03Common StockSEC:0001179110-15-012103:1
- 1,795,752 shares0Common StockSEC:0001179110-15-012103:2
- 8,110 shares0Common StockSEC:0001179110-15-012103:3
- 42 shares0Common StockSEC:0001179110-15-012103:4
- 8,962 shares0Common StockSEC:0001179110-15-009364:0
- 4,000 shares0Common StockSEC:0001179110-15-008950:0
- 20,000 shares@ US$65.69Common StockSEC:0001179110-15-008278:0
- 20,000 shares@ US$65.69Common StockSEC:0001179110-15-008265:0
- 8,462 shares@ US$40.39Common StockSEC:0001179110-15-008396:0
- 38,936 shares@ US$63.16Common StockSEC:0001179110-15-005451:0
- 8,495 shares@ US$43.16Common StockSEC:0001179110-14-015790:0
- 8,495 shares@ US$61.70Common StockSEC:0001179110-14-015790:1
- 1,505 shares@ US$43.16Common StockSEC:0001179110-14-015790:2
- 4,000 shares0Common StockSEC:0001179110-14-009644:0
- 5,458,554 sharesCommon StockSEC:0001179110-14-008481:0
- 7,636 shares@ US$31.57Common StockSEC:0001179110-14-007277:0
- 7,636 shares@ US$60.50Common StockSEC:0001179110-14-007277:1
- 2,364 shares@ US$31.57Common StockSEC:0001179110-14-007277:2
- 4,000 shares0Common StockSEC:0001179110-13-009716:0
- 7,296 shares@ US$34.18Common StockSEC:0001179110-13-005346:0
- 7,296 shares@ US$74.59Common StockSEC:0001179110-13-005346:1
25 of 108 declarations
